Trial site
Augenzentrum Prof. Dr. Koch GmbH
Frankfurt am Main, Germany 60549, GermanyNot linked to an institution yet
The trials here
What the 5 trials at this site are about, from their registry records.
- Phase
- Phase 33 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting3 trials
- Recruiting2 trials
- Lead sponsor
- Hoffmann-La Roche2 trials
- 4d Molecular Therapeutics Inc.1 trial
- ONL Therapeutics1 trial
- Regeneron Pharmaceuticals1 trial
Running trials
Active, not recruiting
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration (4FRONT-2)
2025-521349-25-00· Phase 3· 4d Molecular Therapeutics Inc.· Source
Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
NCT06659445· Phase 2· ONL Therapeutics· Source
Active, not recruiting
A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
NCT06795048· Phase 4· Hoffmann-La Roche· Source
Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
NCT06541704· Phase 3· Regeneron Pharmaceuticals· Source
Active, not recruiting
A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)
NCT04657289· Phase 3· Hoffmann-La Roche· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error